ABSTRACT Early prenatal screening at 26 + 6 weeks detected Citrobacter koseri vaginal colonization in an asymptomatic high‐risk gravida. Culture‐guided IV ceftazidime (susceptible per CLSI testing) eradicated the pathogen without maternal/fetal compromise. Multidisciplinary management prevented vertical transmission, neonatal CNS complications, and yielded a healthy term delivery (Apgar 9/10). Emphasizes susceptibility‐directed antimicrobial stewardship for optimal outcomes in rare pregnancy infections.
Assenza et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: